1. The membrane stabilising activity of drugs and fatal overdose

   Newsletter Article 07 February 2013 Pages: 2 - 2

2. Hepatocellular carcinoma in oral contraceptive users

   Newsletter Article 07 February 2013 Pages: 2 - 2

3. Perineal irritation associated with dexamethasone

   Newsletter Article 07 February 2013 Pages: 2 - 2

4. Ibuprofen and myocardial rupture

   Newsletter Article 07 February 2013 Pages: 2 - 3

5. Non-steroidal anti-inflammatory drugs and renal complications

   Newsletter Article 07 February 2013 Pages: 3 - 3

6. Hepatotoxicity associated with halothane

   Newsletter Article 07 February 2013 Pages: 3 - 3

7. Death following self-poisoning with xylenol

   Newsletter Article 07 February 2013 Pages: 3 - 3

8. Managing theophylline poisoning

   Newsletter Article 07 February 2013 Pages: 3 - 4

9. Sodium nitroprusside toxicity after low doses

   Newsletter Article 07 February 2013 Pages: 4 - 4

10. The efficacy of treatment of paraquat poisoning

    Newsletter Article 07 February 2013 Pages: 4 - 4

11. Antidepressants

    Newsletter Article 07 February 2013 Pages: 4 - 5

12. Auranofin⋆

    Newsletter Article 07 February 2013 Pages: 5 - 5

13. Benzodiazepine withdrawal⋆

    Newsletter Article 07 February 2013 Pages: 5 - 5

14. Beta-blockers

    Newsletter Article 07 February 2013 Pages: 5 - 5

15. Chloroquine + pyrimethamine + sulfadoxine

    Newsletter Article 07 February 2013 Pages: 5 - 6

16. Cyclosporin interaction

    Newsletter Article 07 February 2013 Pages: 6 - 6

17. Cytostatics

    Newsletter Article 07 February 2013 Pages: 6 - 6

18. Deferoxamine

    Newsletter Article 07 February 2013 Pages: 6 - 6

19. Diltiazem see Cyclosporin

    Newsletter Article 07 February 2013 Pages: 6 - 6

20. Diphenhydramine hydrochloride

    Newsletter Article 07 February 2013 Pages: 6 - 6

21. Dipyridamole interaction⋆

    Newsletter Article 07 February 2013 Pages: 6 - 6

22. Distigmine see Dipyridamole

    Newsletter Article 07 February 2013 Pages: 6 - 6

23. Enalapril see Lithium

    Newsletter Article 07 February 2013 Pages: 6 - 6

24. Fluoxetine

    Newsletter Article 07 February 2013 Pages: 6 - 7

25. Heparin

    Newsletter Article 07 February 2013 Pages: 7 - 7

26. Heparin

    Newsletter Article 07 February 2013 Pages: 7 - 7

27. Hydrocortisone

    Newsletter Article 07 February 2013 Pages: 7 - 7

28. Hydrocortisone sodium succinate⋆

    Newsletter Article 07 February 2013 Pages: 7 - 8

29. Indomethacin interaction

    Newsletter Article 07 February 2013 Pages: 8 - 8

30. Interferon alpha

    Newsletter Article 07 February 2013 Pages: 8 - 8

31. Lithium

    Newsletter Article 07 February 2013 Pages: 8 - 8

32. Lithium interaction

    Newsletter Article 07 February 2013 Pages: 8 - 9

33. Magnesium sulfate

    Newsletter Article 07 February 2013 Pages: 9 - 9

34. Methotrexate see Indomethacin

    Newsletter Article 07 February 2013 Pages: 9 - 9

35. Metoclopramide

    Newsletter Article 07 February 2013 Pages: 9 - 9

36. Mitoxantrone

    Newsletter Article 07 February 2013 Pages: 9 - 9

37. Oxatomide

    Newsletter Article 07 February 2013 Pages: 9 - 9

38. Oxymetholone

    Newsletter Article 07 February 2013 Pages: 9 - 10

39. Piroxicam

    Newsletter Article 07 February 2013 Pages: 10 - 10

40. Pyrimethamine see Chloroquine

    Newsletter Article 07 February 2013 Pages: 10 - 10

41. Salbutamol

    Newsletter Article 07 February 2013 Pages: 10 - 10

42. Sodium aurothiomalate

    Newsletter Article 07 February 2013 Pages: 10 - 10

43. Sulfadoxine see Chloroquine

    Newsletter Article 07 February 2013 Pages: 10 - 10

44. Terazosin

    Newsletter Article 07 February 2013 Pages: 10 - 10

45. Triamcinolone⋆

    Newsletter Article 07 February 2013 Pages: 10 - 10

46. Vaccine, deptheria, tetanus and pertussis

    Newsletter Article 07 February 2013 Pages: 10 - 11

47. Ocular toxicity from systemic drug therapy - Part 1

    Newsletter Article 07 February 2013 Pages: 11 - 12

48. Salicylates and Reye’s syndrome

    Newsletter Article 07 February 2013 Pages: 12 - 12